• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Rogers Corporation

Rogers Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Roche receives EU approval for rheumatoid arthritis drug

    Roche receives EU approval for rheumatoid arthritis drug

  2. Roxgold Reports Financial Results For Second Quarter 2014

    Roxgold Reports Financial Results For Second Quarter 2014

  3. Harwood Feffer LLP Announces Investigation of Intermune, Inc.

    Harwood Feffer LLP Announces Investigation of Intermune, Inc.

  4. Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody, a component of Roche's immunotherapy assay

    Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody, a component of Roche's immunotherapy assay

  5. Roche and InterMune Reach Definitive Merger Agreement

    Roche and InterMune Reach Definitive Merger Agreement

  6. Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of InterMune, Inc. Stockholders

    Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of InterMune, Inc. Stockholders

  7. Wide-Moat Funds That Fly Under the Radar

    These quality funds with smaller asset bases have portfolios built around solid companies.

  8. Funds Betting on Big Pharma

    Large drugmakers are out of favor, but some good funds are banking on a rebound.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.